Study reveals how uncertainty about cancer drugs influences patient decisions
NCT ID NCT07110597
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study surveyed over 3,000 US adults to see how explaining different types of uncertainty about a new cancer drug (like whether it works for all races or has unknown side effects) affects people's willingness to take it. Participants read short statements about what is unknown and then rated how likely they would be to try the drug. The goal was to learn how to communicate uncertainty clearly without confusing or misleading patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors and regulators communicate the limits of what is known about new cancer drugs more clearly to patients.
What could go wrong
This is a survey, not a treatment trial. It measures hypothetical decisions, not real-world outcomes, so its impact on actual patient care is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London School of Economics and Political Science
London, United Kingdom